×
Business / Stock Market

Bionano Genomics Has Disappointed, but Its NHS Deal May Turn Things Around

Published Apr 30 2021 at 2:12 PM GMT
Investor Place

Investor Place @investorplace.com

Continue reading at investorplace.com
Key
Points
  • InvestorPlace - Stock Market News, Stock Advice & Trading Tips It's hard to reconcile the sell-off in BNGO stock with Bionano's progress in advancing the Saphyr system - but this presents an opportunity.
Credit
Tags
Continue reading at investorplace.com
Trending

Stats

  • Published Apr 30, 2021 2:12 PM GMT